Safety and Immunogenicity Study of MenC-TT Vaccine (NeisVac-C) in Toddlers Previously Immunized With PCV7 (Prevenar®)

Clinical trial NCT00617760 · COMPLETED

Trial details

NCT number: NCT00617760
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Neisseria Meningitidis (Bacterial Meningitis)Invasive Pneumococcal Disease (IPD)

Start date: 2008-03-01
Primary completion: 2009-08-01
Enrollment: 330

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.